Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/01 → 10/31/02 |
Funding
- Aventis Pharmaceuticals Products Inc: $3,943.00
A Randomized Phase II/III Multicenter Trial of Docetaxel Plus Cisplatin and Docetaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in First Line Treatment
- Arnold, Susanne (PI)